A detailed history of Momentum Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Momentum Advisors, LLC holds 6,983 shares of BMY stock, worth $367,724. This represents 0.52% of its overall portfolio holdings.

Number of Shares
6,983
Previous 6,964 0.27%
Holding current value
$367,724
Previous $495,000 1.41%
% of portfolio
0.52%
Previous 0.55%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $1,301 - $1,540
19 Added 0.27%
6,983 $502,000
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $13 - $7,991
104 Added 1.52%
6,964 $495,000
Q2 2022

Jul 22, 2022

BUY
$72.62 - $79.98 $498,173 - $548,662
6,860 New
6,860 $528,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $112B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Momentum Advisors, LLC Portfolio

Follow Momentum Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Momentum Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Momentum Advisors, LLC with notifications on news.